National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant CyclophosphamideBronwen E. Shaw, Javier Bolaños‐Meade, Xiao-Ying Tang et al.|Journal of Clinical Oncology|2021Cited by 217
Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease ProphylaxisMehdi Hamadani, Mary M. Horowitz, Mei-Jie Zhang et al.|Transplantation and Cellular Therapy|2020Cited by 60
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical TrialBronwen E. Shaw, Javier Bolaños‐Meade, Antonio Martin Jimenez-Jimenez et al.|Transplantation and Cellular Therapy|2022Cited by 55
Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic AnemiaMary Eapen, Mary M. Horowitz, Mei-Jie Zhang et al.|Transplantation and Cellular Therapy|2020Cited by 47